82
66
Growth Score
-5 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
292052
Artificial intelligence- and quantum mechanics-based capabilities to Design, Make, Test, and Analyse novel pharmaceuticals.
- Mark P. Waller: CEO and Founder
- David Cardoso: Vice President, Business Development and Strategy
About the Company
Founded by Professor Mark Waller, Pending AI has developed a comprehensive discovery platform enabled by artificial intelligence and quantum mechanics, ushering in a new paradigm of medicinal innovation where higher-quality small molecule drugs can be developed in a fraction of the time and cost. With operational presences across both Cambridge,
Massachusetts, United States and Eveleigh, New South Wales, Australia, Pending AI is actively seeking research-and-development partnerships with pharmaceutical companies, as well as to ascertain interest from investors in the company's upcoming investment round.
